Jude Fitzgibbon

20PUBLICATIONS
197CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)NeonatologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Feb 06, 2026
PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

Chengqi Xu, Ilkay Us, Jake Cohen-Setton

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Apr 09, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

Fadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen

|Sep 05, 2024
SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma.

Ana Portelinha, Shenqiu Wang, Sara Parsa

|Aug 27, 2024
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.

Emil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley

|Aug 26, 2024
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation.

Vilma Dembitz, Hannah Lawson, Richard Burt

Pageof 4

Frequent Collaborators

8 joint publications

Findlay Bewicke-Copley

7 joint publications

Ana Rio-Machin

5 joint publications

Kevin Rouault-Pierre

5 joint publications

Ari Melnick